(10-271) Effectiveness of Off-Label Increased Dosing of Omalizumab Compared to Standard Dosing for Chronic Spontaneous Urticaria

Wednesday, December 10, 2025

11:00 AM - 12:00 PM

Location: Bayside A, Level 1

Residency Program: The University of Kansas Health System
Residency Program Type: PGY2 (Ambulatory Care Pharmacy)
Residency Program Location: Kansas

Co-Author(s): Rachael Ulbricht, Connor Hayes

Primary Author(s)

Faith Meier, PharmD

PGY2 Ambulatory Care Pharmacy Resident
The University of Kansas Health System